Mugen Ujiie

Institute for Security Studies — KE

Medicine · Health Sciences

20h-index1.8kcitations100works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(21), COVID-19 Clinical Research Studies(18), Mosquito-borne diseases and control(13), COVID-19 epidemiological studies(12), Viral Infections and Vectors(12)

Publications100 total

Pharmacist follow-up of patients prescribed nirmatrelvir/ritonavir: a single-center retrospective analysis
Journal of Pharmaceutical Health Care and Sciences·2025Open Access
Letter to the editor: Migrant tuberculosis in low-incidence Japan; introduction of pre-entry screening
Eurosurveillance·2025· 1 citedOpen Access
Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia
Global Health & Medicine·2025· 2 citedOpen Access
Low Levels of Postvaccination Hemagglutination Inhibition Antibodies and Their Correlation With Influenza Protection Among Healthcare Workers During the 2024–2025 A/H1N1 Outbreak in Japan
The Journal of Infectious Diseases·2025· 1 cited
Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan
Emerging infectious diseases·2025· 14 citedOpen Access
LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial
Clinical Infectious Diseases·2025· 9 cited
Low levels of post-vaccination hemagglutination inhibition antibodies and their correlation with influenza protection among healthcare workers during the 2024/2025 A/H1N1 outbreak in Japan
2025Open Access
P-1395. Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis Against mpox in High-Risk Population: An Open-Label Randomized Trial
Open Forum Infectious Diseases·2025Open Access
Second Japanese Case of Relapsing Fever since 1956
Kansenshogaku zasshi·2024Open Access
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults
The Journal of Infectious Diseases·2024· 35 citedOpen Access
Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis against mpox in a High-Risk Population: An Open-Label Randomized Trial
2024· 4 citedOpen Access
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults
NEJM Evidence·2024· 28 cited
Intestinal protozoa in returning travellers: a GeoSentinel analysis from 2007 to 2019
Journal of Travel Medicine·2024· 10 citedOpen Access
Japan’s contribution to strengthening global health emergency workforce capacity through the Global Outbreak Alert and Response Network
Western Pacific surveillance response journal·2024Open Access
Global Outbreak Alert and Response Network (GOARN) focal point engagement meeting with partners in Japan
Western Pacific surveillance response journal·2024· 2 citedOpen Access
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
New England Journal of Medicine·2023· 384 citedOpen Access
Large-scale resurgence of herpangina in Japan, following the easing of COVID-19 measures
IJID Regions·2023· 4 citedOpen Access
Tetanus Toxoid Antibody Seroprevalence in Japan
Clinical Infectious Diseases·2023· 3 cited
The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine: An observational study
Vaccine·2023· 1 cited
Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study
JMIR Research Protocols·2023· 5 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Norio Ohmagari(33), Tetsuya Suzuki(16), Kayoko Hayakawa(16), Satoshi Kutsuna(15), Masahiro Ishikane(15), Hidetoshi Nomoto(12), Sho Saito(12), Kei Yamamoto(12), Takato Nakamoto(11), Noriko Kinoshita(11), Yusuke Miyazato(11), Yasuyuki Kato(10), Yutaro Akiyama(10), Shinichiro Morioka(10), Shinya Tsuzuki(9), Nozomi Takeshita(9), Shuzo Kanagawa(9), Satoshi Ide(9), Keiji Nakamura(9), Wataru Sugiura(9)